Kamada Ltd. announced the appointment of Michal Stein, M.D., as Vice President and Medical Director for Immunology. Dr. Stein will lead Kamada's medical affairs in all of the company's Immunology and specific IgGs products and indications, such as Type-1 Diabetes, Graft vs. Host Disease (GvHD), transplantations and Anti-Rabies IgG, as well as potential new initiatives. Dr. Stein brings over 15 years of experience in the healthcare industry, including 12 years in increasingly senior positions at multi-national pharmaceutical companies in Israel. Prior to joining Kamada, she served for four years as Medical Director at Sanofi. In this position, Dr. Stein led the medical affairs and pharmacovigilance departments of the Israeli unit of the company, overseeing all aspects of product life-cycle management.